Biomarkers Market Size, Share Demand and Forecast Report 2030
The biomarkers market size was valued at USD 45.1 billion in 2023 and is poised to grow at a significant CAGR of 12.2% during
the forecast period 2024-2030. The growth of the market is majorly driven by rise
in demand and need for the accurate diagnosis.
Biomarkers used in the medical field, are a
part of a relatively new clinical toolset categorized by their clinical
applications. The four main classes are molecular, physiologic, histologic and
radiographic biomarkers. All four types of biomarkers have a clinical role in
narrowing or guiding treatment decisions and follow a sub-categorization of
being either predictive, prognostic, or diagnostic.
View Full Report: https://www.precisionbusinessinsights.com/market-reports/biomarkers-market
The Biomarkers Market segmentation:
1) By Type: Biomarker of Disease, Biomarker of
Exposure.
2) By Application: Disease Diagnosis, Disease Progression, Drug Discovery and
Development, Development of Molecular Diagnostics, Forensic, Others.
3) By End User: Hospitals, Research Organizations, Diagnostic Centers, Others.
Based on its application, and its many
positive attributes, the art of diagnosing a disease based on its indications
and symptoms is known as diagnosis. In the past, the doctor relied on the
patient's medical history, examination, and observation for diagnosis because
there weren't many diagnostic tests accessible. Numerous technological
developments in medicine during the 20th century led to the creation of new
imaging techniques and a broad range of diagnostic tests. The capacity of
physicians to diagnose patients accurately was greatly enhanced by these
advancements.
Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=25364
The prominent key players operating in the Biomarkers
Market is QIAGEN N.V. (Netherlands), Merck Millipore (U.S.), PerkinElmer, Inc.
(U.S.), Enzo Biochem, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Siemens
Healthineers (Germany), Hoffmann-La Roche AG (Switzerland), Thermo Fisher
Scientific, Inc. (U.S.), Abbott Laboratories (U.S.)
Scope of The Report:
·
The Biomarkers Market research
report includes historical data, trending features, and market growth estimates
for the future.
·
The qualitative and
quantitative analysis of the market along with CAGR calculation for the
forecast period.
·
The market report helps to
provide the best results for business enhancement and business growth.
·
The report gives a
comprehensive overview of both primary and secondary data.
·
The market key players covered
here to help them strengthen their place in the market.
About Precision Business Insights:
We are a market research company that strives
to provide the highest quality market research insights. Our diverse market
research experts are enthusiastic about market research and therefore produce
high-quality research reports. We have over 500 clients with whom we have a
good business partnership and capacity to provide in-depth research analysis
for more than 30 countries. In addition to delivering more than 150 custom
solutions, we already have accounts with the top five medical device
manufacturers.
Precision Business Insights offers a variety of cost-effective and
customized research services to meet research requirements. We are a leading
research service provider because of our extensive database built by our
experts and the services we provide.
Contact:
Mr. Satya
Precision Business Insights
| Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number:
852781747
Comments
Post a Comment